Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,259,800 | 857,028 | 527,926 | 247,350 | 1,255,620 |
| Depreciation Amortization | 699,320 | 513,487 | 336,126 | 167,167 | 648,220 |
| Income taxes - deferred | 113,790 | 1,657 | 692 | -3,459 | 15,913 |
| Accounts receivable | -276,211 | -201,091 | -120,994 | -81,130 | -52,248 |
| Accounts payable and accrued liabilities | 113,822 | 117,115 | 41,652 | 41,018 | -3,743 |
| Other Working Capital | -245,810 | -130,622 | -332,015 | -338,143 | 136,170 |
| Other Operating Activity | 196,679 | 116,246 | 108,220 | 79,491 | 34,868 |
| Operating Cash Flow | $1,861,390 | $1,273,820 | $561,607 | $112,294 | $2,034,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -919,950 | -638,739 | -414,968 | -197,151 | -728,090 |
| Net Acquisitions | 8,250 | -1,045,050 | -431,387 | -134,776 | 18,270 |
| Other Investing Activity | -1,779,050 | 0 | 0 | 0 | -495,720 |
| Investing Cash Flow | $-2,690,750 | $-1,683,789 | $-846,355 | $-331,927 | $-1,205,540 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 501,176 | 480,209 | 295,620 | 112,378 | 400,196 |
| Debt Issued | 2,910,611 | 1,616,470 | 786,242 | 271,544 | 441,278 |
| Debt Repayment | -1,647,978 | -1,118,729 | -450,277 | -267,486 | -617,499 |
| Common Stock Issued | 107,047 | 86,403 | 40,753 | 5,807 | 111,300 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -505,014 |
| Dividend Paid | -317,900 | -317,903 | -317,903 | N/A | -296,130 |
| Other Financing Activity | -747,946 | -438,436 | -107,065 | -6,032 | -342,171 |
| Financing Cash Flow | $805,010 | $308,014 | $247,370 | $116,211 | $-808,040 |
| Exchange Rate Effect | -24,570 | 6,682 | -861 | -5,228 | -26,480 |
| Beginning Cash Position | 682,770 | 682,777 | 682,777 | 682,777 | 688,040 |
| End Cash Position | 633,850 | 587,504 | 644,538 | 574,127 | 682,770 |
| Net Cash Flow | $-48,920 | $-95,273 | $-38,239 | $-108,650 | $-5,260 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,861,390 | 1,273,820 | 561,607 | 112,294 | 2,034,800 |
| Capital Expenditure | -931,627 | -646,371 | -419,259 | -199,631 | -747,938 |
| Free Cash Flow | 929,763 | 627,449 | 142,348 | -87,337 | 1,286,862 |